NCT00370006View on ClinicalTrials.gov

Phase 1 Trial of CMV Towne Vaccine in Subjects Previously Received VCL CT02 Vaccine ID or IM

PHASE1CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

September 30, 2006

Study Completion Date

August 31, 2007

Conditions
Cytomegalovirus Infection
Interventions
BIOLOGICAL

Towne CMV vaccine

Sponsors

Collaborators (1)

Vical
All Listed Sponsors
collaborator

Vical

INDUSTRY

lead

University of California, San Francisco

OTHER